| |
 |
|
Class Information
Number: 530/867
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof > Involving immunoglobulin or antibody produced via recombinant dna technology
Description: Subject matter involving an immunoglobulin or antibody produced via recombinant DNA technology.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7566772 |
Antibodies against interleukin-1.beta. |
Jul. 28, 2009 |
| 7446182 |
Recombinant antibodies for the detection and neutralization of anthrax toxin |
Nov. 4, 2008 |
| 7422739 |
Anti-CD20 antibodies |
Sep. 9, 2008 |
| 7364737 |
Human neutralizing monoclonal antibodies to respiratory syncytial virus |
Apr. 29, 2008 |
| 7276375 |
Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate |
Oct. 2, 2007 |
| 7157562 |
Bioprocess for the production of recombinant anti-botulinum toxin antibody |
Jan. 2, 2007 |
| 7037496 |
Chimeric immunoglobulin for CD4 receptors |
May. 2, 2006 |
| 6808902 |
Process for correction of a disulfide misfold in IL-1ra FC fusion molecules |
Oct. 26, 2004 |
| 6806070 |
Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
Oct. 19, 2004 |
| 6787153 |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
Sep. 7, 2004 |
| 6685942 |
Human neutralizing monoclonal antibodies to respiratory syncytial virus |
Feb. 3, 2004 |
| 6682734 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
Jan. 27, 2004 |
| 6642356 |
Peptides which function as hinge regions in protein |
Nov. 4, 2003 |
| 6566082 |
T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions |
May. 20, 2003 |
| 6551593 |
Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through .alpha. 4 .beta. 7 and its ligands and madcam |
Apr. 22, 2003 |
| 6495137 |
Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chains |
Dec. 17, 2002 |
| 6491916 |
Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies |
Dec. 10, 2002 |
| 6441141 |
Synthetic peptides, antibodies against them and their use |
Aug. 27, 2002 |
| 6399061 |
Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma |
Jun. 4, 2002 |
| 6359126 |
Antibodies to .alpha.v.beta.3 integrin |
Mar. 19, 2002 |
| 6312690 |
Monoclonal recombinant anti-rhesus D (D7C2) antibody |
Nov. 6, 2001 |
| 6287817 |
Fusion proteins for protein delivery |
Sep. 11, 2001 |
| 6274324 |
Specific binding reagent comprising a variable domain protein linked to a support or tracer |
Aug. 14, 2001 |
| 6172197 |
Methods for producing members of specific binding pairs |
Jan. 9, 2001 |
| 6132722 |
Recombinant antibody-enzyme fusion proteins |
Oct. 17, 2000 |
| 6072041 |
Fusion proteins for protein delivery |
Jun. 6, 2000 |
| 6042828 |
Humanized antibodies to ganglioside GM.sub.2 |
Mar. 28, 2000 |
| 5990297 |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
Nov. 23, 1999 |
| 5969108 |
Methods for producing members of specific binding pairs |
Oct. 19, 1999 |
| 5895811 |
Artificial positive controls derived from bifunctional conjugates |
Apr. 20, 1999 |
| 5885793 |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
Mar. 23, 1999 |
| 5874255 |
DNA encoding humanized antibodies specific for the ganglioside GM.sub.2 |
Feb. 23, 1999 |
| 5858725 |
Preparation of chimaeric antibodies using the recombinant PCR strategy |
Jan. 12, 1999 |
| 5858682 |
E2A/pbx1 fusion protein specific monoclonal antibodies |
Jan. 12, 1999 |
| 5843439 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
Dec. 1, 1998 |
| 5837821 |
Antibody construct |
Nov. 17, 1998 |
| 5834187 |
Sequence and analysis of LKP pilin structural genes and the LKP pili operon of nontypable Haemophilus influenzae |
Nov. 10, 1998 |
| 5827690 |
Transgenic production of antibodies in milk |
Oct. 27, 1998 |
| 5776456 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
Jul. 7, 1998 |
| 5767246 |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
Jun. 16, 1998 |
| 5759546 |
Treatment of CD4 T-cell mediated conditions |
Jun. 2, 1998 |
| 5747654 |
Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
May. 5, 1998 |
| 5736137 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
Apr. 7, 1998 |
| 5677425 |
Recombinant antibody |
Oct. 14, 1997 |
| 5674712 |
Recombinant vector and use thereof for exocellular preparation of antibodies in single molecule form from Bacillus subtilis |
Oct. 7, 1997 |
| 5653980 |
Vaccine comprising part of constant region of IgE for treatment of IgE-mediated allergic reactions |
Aug. 5, 1997 |
| 5631158 |
Methods and compositions for high protein production from non-native DNA |
May. 20, 1997 |
| 5608039 |
Single chain B3 antibody fusion proteins and their uses |
Mar. 4, 1997 |
| 5565332 |
Production of chimeric antibodies - a combinatorial approach |
Oct. 15, 1996 |
| 5558864 |
Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies |
Sep. 24, 1996 |
|
|
|
